Literature DB >> 12700469

High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid.

Laurence Vergne, Dimitris Paraskevis, Anne-Mieke Vandamme, Eric Delaporte, Martine Peeters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12700469     DOI： 10.1097/00002030-200305020-00028

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.

Authors:  Alexandra U Scherrer; Bruno Ledergerber; Viktor von Wyl; Jürg Böni; Sabine Yerly; Thomas Klimkait; Cristina Cellerai; Hansjakob Furrer; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Pietro L Vernazza; Enos Bernasconi; Huldrych F Günthard
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

2.  The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness.

Authors:  Harr F Njai; Youssef Gali; Guido Vanham; Claude Clybergh; Wim Jennes; Nicole Vidal; Christelle Butel; Eitel Mpoudi-Ngolle; Martine Peeters; Kevin K Ariën
Journal:  Retrovirology       Date:  2006-07-03       Impact factor: 4.602
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.